Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

combination ranibizumab + bromfenac

ranibizumab injection in study eye each month for 4 months then as needed each month for 8 months. Plus one drop of bromfenac in the study eye twice per day, each day, for 12 months.

DRUG

ranibizumab injection alone

ranibizumab injection in study eye each month for 4 months then as needed each month for 8 months

Trial Locations (1)

97239

Casey Eye Institute at Oregon Health & Science University, Portland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Oregon Health and Science University

OTHER